Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
SUO 2022: Intermediate Risk Non-Muscle Invasive Bladder Cancer: “New ...
AUA 2025: Active Surveillance for Low-Grade Intermediate Risk Bladder
AUA 2024: Management of Recurrent Low Grade Intermediate Risk Bladder ...
Intermediate Risk Bladder Cancer: Understanding Your Treatment Options ...
Risk of bladder cancer death for low-and intermediate-risk patients ...
Risk stratification of bladder cancer | Download Scientific Diagram
(PDF) Validation of non‐muscle‐invasive bladder cancer risk ...
AUA 2024: Long Term Outcomes of Low and Intermediate Risk Bladder ...
PPT - Bladder cancer risk factor PowerPoint Presentation, free download ...
Bladder Cancer Academy 2017: AUA Guidelines: Non-Muscle Invasive ...
Non muscle invasive bladder cancer treatment - WCRJ
Urinary Bladder Cancer - Dr Puneet Ahluwalia
Bladder Cancer Grading
Performance of Xpert® Bladder Cancer Monitor in low-, intermediate- and ...
Guidelines for surveillance of nonmuscle invasive bladder cancer 2 ...
(PDF) Intermediate and high-risk non-muscle-invasive bladder cancer: an ...
Non–muscle invasive bladder cancer pathways adapted from World J Urol ...
Decision tree for non-muscle-invasive bladder cancer treatment ...
(PDF) Guidance of adjuvant instillation in intermediate risk non ...
PD30-01: Defining intermediate-risk non-Muscle invasive bladder cancer ...
Trial Design Considerations for Intermediate Risk Non Muscle-Invasive ...
Bladder Cancer
AUA 2021: AUA Guideline Amendment: Non-Muscle Invasive Bladder Cancer ...
Overcoming Barriers to Progress in Non-muscle Invasive Bladder Cancer ...
EAU 2024: Defining Intermediate-Risk Non-Muscle Invasive Bladder Cancer ...
Non-Muscle Invasive Bladder Cancer Treatment | Novel Therapies
UroGen's ZUSDURI (mitomycin) Now Approved by FDA for Bladder Cancer ...
(PDF) Intravesical chemotherapy for intermediate risk non‑muscle ...
Stratification of Intermediate-risk Non–muscle-invasive Bladder Cancer ...
Management of Non-Muscle Invasive Bladder Cancer
Table 1 from Defining and treating the spectrum of intermediate risk ...
Women Bladder Cancer
Low-Grade Intermediate-Risk Non–Muscle-Invasive Bladder Cancer
Frontiers | Intermediate and high-risk non-muscle-invasive bladder ...
Bladder Cancer Guidelines - Cancer Therapy Advisor
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer ...
WSAUA 2025: Treatment of Low Grade Intermediate Risk Non Muscle ...
The Latest Research on Bladder Cancer - UroToday
The International Bladder Cancer Group Intermediate-Risk Non-muscle ...
Intermediate risk NMI: Follow-up - Activity Eight: Optimal Surveillance ...
Intravesical chemotherapy for intermediate risk non-muscle invasive ...
Intermediate-risk Non–muscle-invasive Bladder Cancer: Updated Consensus ...
Bladder Cancer: Non-Muscle Invasive Guideline - American Urological ...
carcinoma urinary bladder management
Intermediate-risk Non–muscle-invasive Bladder Cancer: Recommendations ...
Non-Muscle-Invasive Bladder Cancer: Review of Diagnosis and Management ...
Non-muscle Invasive Bladder Cancer: Diagnosis & Treatment
SUO 2023: Primary Chemoablation for Recurrent Low Grade Intermediate ...
Clinical Decision Making in Surveillance of Non–Muscle-Invasive Bladder ...
Treatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder ...
Guideline recommendation for low-risk non-muscle-invasive bladder ...
Experimental and New Approaches For Bladder Preservation in ...
FDA Approves Zusduri (Mitomycin) for Recurrent Low-Grade Intermediate ...
Impact of Pathologic Re-Review on Grade, Clinical Stage, and Risk ...
Noninvasive Bladder Cancer: Diagnosis and Management | MDedge
Table 1 from The management of non-muscle-invasive bladder cancer: A ...
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: Aua/Asco ...
Table 1 from Intravesical Therapy for Non-muscle Invasive Bladder ...
Scientific research : Guidance of adjuvant instillation in intermediate ...
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder ...
MP13-17 CHARACTERIZING INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER ...
Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder ...
Chemohyperthermia with Mitomycin C and COMBAT system in High Risk Non ...
Bladder cancer: management - The Pharmaceutical Journal
(PDF) Current clinical practice gaps in the treatment of intermediate ...
Classification of bladder cancer. | Download Scientific Diagram
Bladder Cancer: Surgical Treatment (TURB and Cystectomy)
Guideline definitions of low-, intermediate- and high-risk ...
Comprehensive Treatment Options for Non-Muscle Invasive Urothelial ...
Recommendations for Managing Intermediate-Risk NMIBC | www ...
Proposed substratification of intermediate-risk non-muscle-invasive ...
SUO 2023: Treatment of Low-grade, Intermediate-risk Non-muscle Invasive ...
NMIBC - URORESIDENT.COM
(PDF) The optimal intravesical maintenance chemotherapy scheme for the ...
UGN-102 Chemoablation for Recurrent Low-Grade Nonmuscle-Invasive ...
(PDF) Guidance of adjuvant instillation in intermediate-risk non-muscle ...
(PDF) Intravesical Therapy in Patients with Intermediate-risk Non ...
AUA 2021: Intravesical Therapy in Patients with Intermediate-Risk Non ...
AUA 2025: Treatment of Recurrent Low-Grade Intermediate-Risk Non-Muscle ...
Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive ...
ASCO GU 2021: Deintensification of Management of Low-Risk Non-Muscle ...
Clinical Validation of the Intermediate-risk Non–muscle-invasive ...
(PDF) Intensive Intravesical Mitomycin C Therapy in Non-Muscle-Invasive ...
Recent advancements in the diagnosis and treatment of non‐muscle ...
Towards Defining Follow-up Strategies for Patients with Primary ...
Intravesical Therapy in Patients with Intermediate-risk Non–muscle ...
ASCO 2025: Impact of Tumor Burden or Focality in Recurrent Low-Grade ...
Refining Active Surveillance Eligibility in Intermediate-risk Non ...
Recirculant Hyperthermic IntraVEsical Chemotherapy HIVEC in ...
ASCO 2025: Trials-in-Progress – Intravesical Sacituzumab Tirumotecan in ...
%3Amax_bytes(150000)%3Astrip_icc()%2FVWH_Illustration_Stages-of-Bladder-Cancer_Laura-Porter_Final-df3daf66b7f84175b9e13c6c86fd234d.jpg&w=3840&q=75)
